Department of Pharmacy, Tongji Hospital Affiliated Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang avenue, Wuhan, 430030, Hubei, China.
Pharmacol Rep. 2021 Oct;73(5):1230-1239. doi: 10.1007/s43440-021-00227-1. Epub 2021 Feb 17.
Baicalin is the main active component of Scutellaria baicalensis, widely used in traditional Chinese medicine thanks to its various pharmacological effects, such as anti-tumor, anti-inflammatory, and antibacterial properties, as well as cardiovascular, hepatic, and renal protective effect. Recently, the protective effects of baicalin on liver disease have received much more attention. Several studies showed that baicalin protects against several types of liver diseases including viral hepatitis, fatty liver disease, xenobiotic induced liver injury, cholestatic liver injury, and hepatocellular carcinoma, with a variety of pharmacological mechanisms. A comprehensive understanding of the mechanism of baicalin can provide a valuable reference for its clinical use, but up to now, no narrative review is available that summarizes the pharmacological effects of baicalin to clarify its potential use in the treatment of liver diseases. Therefore, this review summarizes the progress of baicalin research and the underlying mechanism in the treatment of various liver diseases, to promote further research and its clinical application.
黄芩苷是黄芩的主要活性成分,由于其具有多种药理作用,如抗肿瘤、抗炎和抗菌作用,以及心血管、肝脏和肾脏保护作用,在中国传统医学中被广泛应用。最近,黄芩苷对肝病的保护作用受到了更多的关注。多项研究表明,黄芩苷可预防多种类型的肝病,包括病毒性肝炎、脂肪肝、外源化合物诱导的肝损伤、胆汁淤积性肝损伤和肝癌,具有多种药理机制。全面了解黄芩苷的作用机制可为其临床应用提供有价值的参考,但到目前为止,尚无综述性评论总结黄芩苷的药理作用,以阐明其在治疗肝病方面的潜在用途。因此,本综述总结了黄芩苷在治疗各种肝病中的研究进展及其潜在机制,以促进进一步的研究及其临床应用。
Pharmacol Rep. 2021-10
Toxicol Appl Pharmacol. 2011-10-14
World J Gastroenterol. 2022-7-14
Biomed Pharmacother. 2018-12-24
Front Microbiol. 2025-7-14
ACS Omega. 2025-7-4
World J Gastroenterol. 2025-7-14
Toxicol Rep. 2025-5-10
Naunyn Schmiedebergs Arch Pharmacol. 2025-5
Medicine (Baltimore). 2024-12-6
J Food Biochem. 2021-1
Biochem Biophys Res Commun. 2020-3-12
Pharmacol Rep. 2020-1-8
Curr Transplant Rep. 2019